ACE2 and metabolic dysfunction-associated steatotic liver disease: Activation of the ACE2/Ang1–7/MAS axis downregulates hepatic lipid uptake and lipogenesis, favouring lipid oxidation, and mitochondrial function, improving glucose metabolism14,15 and reducing oxidative stress, inflammation, and liver fibrosis in murine models of NAFLD.16